直 Japanese PDF Font
  • 弁護士等
  • 業務内容
  • 論文等
  • オフィス
  • 事務所概要
  • 採用情報
Finnegan
  • 最新情報
  • Finneganについて
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • プロボノ活動
  • 事務所運営管理
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

James R. Barney

Split Fed. Circ. Won’t Review Toss of $30M Dow Patent Award

December 17, 2015

Law360

On December 17, 2015, the Federal Circuit declined to review a decision which tossed $30 million in supplemental damages that was awarded to Dow Chemical Co. from a dispute with Finnegan client NOVA Chemicals Corp.

In 2010, a district court found that NOVA infringed Dow's patent. As a result of the case, Dow was awarded $30 million in supplemental damages for NOVA's sales during 2010 and 2011. However, soon after Dow was awarded supplemental damages, the Supreme Court handed down its decision in Nautilus. NOVA appealed the supplemental damages decision and the Federal Circuit held that the difference in the indefiniteness standard before and after Nautilus was so significant that while Dow's patents were valid under the old standard, they are invalid under the new one. The Federal Circuit therefore threw out the $30 million award. Dow urged for a rehearing, but the Federal Circuit declined.

Tags

United States Court of Appeals for the Federal Circuit (CAFC), Nautilus Inc. v. Biosig Instrument Inc., NOVA Chemicals Corp., damages

Related Practices

グローバルな知的財産権利の執行、訴訟、および裁判

Related Industries

化学

Related News

Press Release

Finnegan Secures Summary Determination of No Violation in ITC Vehicle Space Guards Investigation for Drop Stop

October 6, 2026

Commentary

Federal Circuit Revives Whistleblower Complaint Over VA's AI Claims-Processing Tool

September 25, 2026

Award/Ranking

Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027

September 24, 2026

Award/Ranking

Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026

September 23, 2026

Press Release

Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower

September 23, 2026

Commentary

New Thomas Pink Womenswear Lines Strain ‘Pink’ Pact with Victoria’s Secret

September 21, 2026

Commentary

Pepsi's U.S. Trademark Dispute Could Reshape Brand Choices, Lawsuit Strategy, Lawyers Say

September 17, 2026

Commentary

Jellycat’s ‘Dupe’ Dilemma: Can IP Protect a ‘Cute’ Aesthetic?

September 16, 2026

Award/Ranking

Finnegan Wins “Hatch-Waxman Litigation Firm of the Year – Branded” and David Weingarten Wins “Patent Strategy Attorney of the Year (South)” at the LMG Life Sciences Americas Awards

September 11, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • プライバシー
  • 免責事項
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP